Lower levels of the aggregation-prone peptide A β42 (or A β42/A β40 ratio) together with increased levels of p-tau and total-tau (t-tau) are a core cerebrospinal fluid (CSF) signature of AD [6]. This evidence concerns the gene MAPT and Alzheimer disease.